Skip to main content
QURE
NASDAQ Life Sciences

uniQure Secures $259M in Share Sale to Fund Gene Therapy Programs

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$49.31
Mkt Cap
$3.07B
52W Low
$8.73
52W High
$71.5
52W Position info
465% above low
Off High info
31% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

QURE has more than doubled off its 52-week low of $8.73.

Summary

uniQure completed a share sale, raising approximately $259 million gross by selling 5.69 million shares at $45.50. This substantial capital infusion follows the recent pricing of the offering and shareholder approval for increased share capital. The funds are critical for advancing the company's AMT-130 gene therapy programs, including commercialization efforts and R&D. This financing provides a significant runway, enabling the company to pursue its regulatory and development goals, especially after the FDA agreed to accept 3-year Phase I/II data for AMT-130. A Biologic License Application (BLA) submission for AMT-130 is planned for Q3 2026. Mizuho also raised its price target to $68.

At the time of this announcement, QURE was trading at $49.31 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.1B. The 52-week trading range was $8.73 to $71.50. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

QURE - Latest Insights

QURE
Nov 04, 2026, 7:28 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $22.60
Real-time Price: $23.84 info
Change: +$1.25 (+6%) info
Market Cap: $1.724B info
QURE
Nov 04, 2026, 7:10 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $22.44
Real-time Price: $23.84 info
Change: +$1.40 (+6%) info
Market Cap: $1.724B info
QURE
Nov 02, 2026, 7:05 AM EST
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $27.66
Real-time Price: $23.84 info
Change: -$3.81 (-14%) info
Market Cap: $1.724B info
QURE
Sep 29, 2026, 9:26 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $22.00
Real-time Price: $23.84 info
Change: +$1.84 (+8%) info
Market Cap: $1.724B info
QURE
Sep 29, 2026, 9:05 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $22.20
Real-time Price: $23.84 info
Change: +$1.64 (+7%) info
Market Cap: $1.724B info